{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:22:41Z","timestamp":1788394961747,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Canada Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Understanding the epidemiology of invasive Candida infections is essential to patient management decisions and antifungal stewardship practices. This study characterized the species distribution and antifungal susceptibilities of prospectively collected isolates of Candida species causing bloodstream infections (BSIs) in patients admitted to tertiary care hospitals located in 14 cities across 8 of the 10 Canadian provinces between 2011 and 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Antifungal susceptibility testing was performed by broth microdilution using CLSI methods, breakpoints and epidemiological cut-off values. DNA sequencing of fks loci was performed on all echinocandin-non-susceptible isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Candida albicans (49.6%), Candida glabrata (20.8%) and Candida parapsilosis complex (12.0%) were the most common species out of 1882 isolates associated with BSIs. Candida tropicalis (5.2%), Candida krusei (4.3%), Candida dubliniensis (4.1%), Candida lusitaniae (1.4%) and Candida guilliermondii (1.1%) were less frequently isolated. Between 2011 and 2016, the proportion of C. albicans significantly decreased from 60.9% to 42.1% (P\u205f&lt;\u205f0.0001) while that of C. glabrata significantly increased from 16.4% to 22.4% (P\u205f=\u205f0.023). C. albicans (n\u205f=\u205f934), C. glabrata (n\u205f=\u205f392) and C. parapsilosis complex (n\u205f=\u205f225) exhibited 0.6%, 1.0% and 4.9% resistance to fluconazole and 0.1%, 2.5% and 0% resistance to micafungin, respectively. Mutations in fks hot-spot regions were confirmed in all nine micafungin non-susceptible C. glabrata.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antifungal resistance in contemporary isolates of Candida causing BSIs in Canada is uncommon. However, the proportion of C. glabrata isolates has increased and echinocandin resistance in this species has emerged. Ongoing surveillance of local hospital epidemiology and appropriate antifungal stewardship practices are necessary to preserve the utility of available antifungal agents.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkz287","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:10:01Z","timestamp":1561662601000},"page":"iv48-iv54","source":"Crossref","is-referenced-by-count":43,"title":["Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011\u201316 study"],"prefix":"10.1093","volume":"74","author":[{"given":"Jeff","family":"Fuller","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"},{"name":"Division of Microbiology, London Health Sciences Centre, 800 Commissioners Road E, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanis C","family":"Dingle","sequence":"additional","affiliation":[{"name":"Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bull","sequence":"additional","affiliation":[{"name":"Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Shokoples","sequence":"additional","affiliation":[{"name":"Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Laverdi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Medicine, Microbiology and Infectious Diseases, H\u00f4pital Maisonneuve-Rosemont, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R","family":"Baxter","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology\/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology\/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada"},{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Karlowsky","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology\/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada"},{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G","family":"Zhanel","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology\/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe R S","family":"Lagac\u00e9-Wiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Walkty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Blondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Slinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Delport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Laverdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Roscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Matukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Goyette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bergevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"2019091012394167900_dkz287-B1","doi-asserted-by":"crossref","first-page":": e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019091012394167900_dkz287-B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2019091012394167900_dkz287-B3","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2019091012394167900_dkz287-B4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care\u2013associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"2019091012394167900_dkz287-B5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2019091012394167900_dkz287-B6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019091012394167900_dkz287-B7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"2019091012394167900_dkz287-B8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019091012394167900_dkz287-B9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2014\/308169","article-title":"The prospective antifungal therapy alliance\u00ae registry: a two-centre Canadian experience","volume":"25","author":"Haider","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2019091012394167900_dkz287-B10","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2019091012394167900_dkz287-B11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019091012394167900_dkz287-B12","doi-asserted-by":"crossref","first-page":"ofv163.","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2019091012394167900_dkz287-B13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2019091012394167900_dkz287-B14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2019091012394167900_dkz287-B15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10096-017-2922-y","article-title":"Serious fungal infections in Canada","volume":"36","author":"Dufresne","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019091012394167900_dkz287-B16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jac\/dki258","article-title":"Invasive Candida species infections: a 5 year population-based assessment","volume":"56","author":"Laupland","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2019091012394167900_dkz287-B17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1155\/2008\/634046","article-title":"Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: report on 453 cases between 2003 and 2005","volume":"19","author":"St-Germain","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2019091012394167900_dkz287-B18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.diagmicrobio.2010.10.026","article-title":"Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007\u20132009 study","volume":"69","author":"Adam","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019091012394167900_dkz287-B19","first-page":"14","article-title":"Epidemiology of candidemia at a tertiary Canadian hospital, 2004\u20132013","volume":"3","author":"Remington","year":"2018","journal-title":"Off J Assoc Med Microbiol Infect Dis Canada"},{"key":"2019091012394167900_dkz287-B20","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts\u2014Fourth Edition: M27","year":"2017"},{"key":"2019091012394167900_dkz287-B21","volume-title":"Performance Standards for Susceptibility Testing of Yeasts\u2014First Edition: M60","year":"2017"},{"key":"2019091012394167900_dkz287-B22","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/JCM.02481-13","article-title":"Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria","volume":"52","author":"Pfaller","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019091012394167900_dkz287-B24","volume-title":"Epidemiological Cutoff Values for Antifungal Susceptibility Testing\u2014Second Edition: M59.","year":"2017"},{"key":"2019091012394167900_dkz287-B25","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.01711-09","article-title":"Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains","volume":"54","author":"Castanheira","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B26","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JCM.00946-09","article-title":"Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2019091012394167900_dkz287-B27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2019091012394167900_dkz287-B28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2019091012394167900_dkz287-B29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019091012394167900_dkz287-B30","doi-asserted-by":"crossref","first-page":"e0120452.","DOI":"10.1371\/journal.pone.0120452","article-title":"Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008\u20132013: results from population-based surveillance","volume":"10","author":"Cleveland","year":"2015","journal-title":"PLoS One"},{"key":"2019091012394167900_dkz287-B31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B32","doi-asserted-by":"crossref","first-page":"e00655","DOI":"10.1128\/mBio.00655-16","article-title":"Heteroresistance to fluconazole is a continuously distributed phenotype among Candida glabrata clinical strains associated with in vivo persistence","volume":"7","author":"Ben-Ami","year":"2016","journal-title":"MBio"},{"key":"2019091012394167900_dkz287-B33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008\u20132009)","volume":"38","author":"Pfaller","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"2019091012394167900_dkz287-B34","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","article-title":"Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2019091012394167900_dkz287-B35","doi-asserted-by":"crossref","first-page":"e00906","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2019091012394167900_dkz287-B37","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B38","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.00443-09","article-title":"Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-\u03b2-d-glucan synthase: implication for the existing susceptibility breakpoint","volume":"53","author":"Garcia-Effron","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B39","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B40","first-page":"52","article-title":"Recurrent echinocandin-resistant Candida glabrata candidemia following prolonged micafungin treatment for multiple intra-abdominal abscesses: a case report","volume":"3","author":"Zhou","year":"2018","journal-title":"Off J Assoc Med Microbiol Infect Dis Canada"},{"key":"2019091012394167900_dkz287-B41","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B42","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01451-13","article-title":"Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019091012394167900_dkz287-B43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019091012394167900_dkz287-B44","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/Supplement_4\/iv48\/29198075\/dkz287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T07:45:58Z","timestamp":1610091958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/Supplement_4\/iv48\/5553081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":44,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2019,8,23]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz287","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,8,1]]}}}